ArticleTrials2020

Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)-study protocol for a multicentre, randomized phase III trial.

Sanjoy Chatterjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.